At a daily press conference on Wednesday, China’s Foreign Ministry Spokesman Zhao Lijian rejected a report published Tuesday, citing that Beijing delayed COVID-19 information sharing with the World Health Organization (WHO).
On Tuesday, citing the internal documents, emails and dozens of interviews, the Associated Press (AP) reported that the “Chinese officials sat on releasing the genetic map, or genome, of the deadly coronavirus (COVID-19) for over a week after multiple government labs had fully decoded it, not sharing details key to designing tests, drugs and vaccines.”
China’s response to the controversial report fails to spoil the upbeat market mood, with USD/JPY challenging daily highs near 107.80 amid a rally in the global stocks and US equity futures. AUD/USD, however, reversed the rally to five-month tops of 0.6983 and now trades flat at 0.6890.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.